Markets:

Overview

News

Currencies

International

Treasuries

Sangamo Therapeutics, Inc. - Common Stock (NQ:SGMO)

0.3968 -0.0032 (-0.80%)

Streaming Delayed Price Updated: 10:18 AM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sangamo Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Sangamo Therapeutics Announces Research Evaluation and Option Agreement With Prevail, a Wholly Owned Subsidiary of Lilly, for Novel Engineered Capsids

July 17, 2023

From Sangamo Therapeutics, Inc.

Via Business Wire

Sangamo Therapeutics and Voyager Therapeutics Enter License Agreement for Epigenetic Regulation Treatment of Prion Disease

June 29, 2023

From Sangamo Therapeutics, Inc.

Via Business Wire

Sangamo Therapeutics Receives U.S. FDA Fast Track Designation for Isaralgagene Civaparvovec for the Treatment of Fabry Disease

May 22, 2023

From Sangamo Therapeutics, Inc.

Via Business Wire

The Latest Analyst Ratings for Sangamo Therapeutics ↗

May 01, 2023

Via Benzinga

Sangamo Therapeutics's Return On Capital Employed Overview ↗

May 01, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

May 31, 2023

During Wednesday's session, 212 companies made new 52-week lows.

Via Benzinga

Sangamo Therapeutics Announces Appointment of Lisa Rojkjaer, M.D., as Chief Medical Officer

May 16, 2023

From Sangamo Therapeutics, Inc.

Via Business Wire

Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May ↗

May 11, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

Sangamo Therapeutics's Earnings Outlook ↗

April 25, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

March 15, 2023

On Wednesday, 479 stocks made new 52-week lows.

Via Benzinga

What 4 Analyst Ratings Have To Say About Sangamo Therapeutics ↗

March 03, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

May 08, 2023

On Monday, 61 companies hit new 52-week lows.

Via Benzinga

Sangamo Therapeutics to Present Pre-clinical Data From Its Genomic Engineering Platform at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

May 02, 2023

From Sangamo Therapeutics, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2023 ↗

April 28, 2023

Via Benzinga

Soon After Novartis & Biogen Walked Away From Neurology Drug Partnerships, Sangamo Announces Major Restructuring ↗

April 27, 2023

Sangamo Therapeutics Inc (NASDAQ: SGMO) announced cutting 27% of its workforce, prioritizing its pipeline, and changing its corporate structure to save about $31 million to fund operations for at least...

Via Benzinga

Sangamo Therapeutics Announces Strategic Update and Reports Preliminary First Quarter 2023 Financial Results

April 26, 2023

From Sangamo Therapeutics, Inc.

Via Business Wire

Sangamo Therapeutics Announces First Quarter 2023 Conference Call and Webcast

April 19, 2023

From Sangamo Therapeutics, Inc.

Via Business Wire

This Biotech's Stock Has Been Under Pressure, Could Upcoming Clinical Trials Of Its Nanotechnology-Based COVID Drug Candidate Be The Start Of An Upward March? ↗

April 19, 2023

A company that seems to have seen poor market sentiment lately is NanoViricides Inc. (NYSEAMERICAN: NNVC), a pharmaceutical company specializing in the development of nanomedicine drugs for treating...

Via Benzinga

7 Sorry Pharma Stocks to Sell in April Before It’s Too Late ↗

April 16, 2023

You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards.

Via InvestorPlace

Boeing, Spirit AeroSystems And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

April 14, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

April 10, 2023

Monday's session saw 114 companies set new 52-week lows.

Via Benzinga

The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket ↗

March 25, 2023

Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it.

Via InvestorPlace

Two Big Pharma Companies Bow Out Of Neurology Drug Partnerships With Sangamo ↗

March 20, 2023

Two big-name partners have walked away from partnerships with Sangamo Therapeutics Inc (NASDAQ: SGMO) over a few days.

Via Benzinga

UBS Group, Credit Suisse And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

March 20, 2023

U.S. stock futures traded mostly lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 17, 2023

Via Benzinga

10 Companies That Had Tons of Money in SVB When It Collapsed ↗

March 13, 2023

Silicon Valley Bank is gone but its clients are still here. Many prominent companies, and not just startups, had money in SVB.

Via InvestorPlace

Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank ↗

March 11, 2023

The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 27, 2023 ↗

February 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 27, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 24, 2023

On Friday, 135 companies reached new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sangamo Therapeutics, Inc. - Common Stock (NQ:SGMO)

All News about Sangamo Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today